Darko Kaštelan - Concepedia

Author

Darko Kaštelan

Also Known As

D Kastelan, D Kaštelan, D. Kastelan, D. Kaštelan, Darko Kastelan, Darko Kaštelan, J Kirchner, Kaštelan Darko, Kaštelan, Darko, Zibar Tomšić, Karin

245

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University Hospital Centre Zagreb University of Zagreb University of Turin LMU Klinikum Radboud University Nijmegen

About

Darko Kaštelan is an author at University Hospital Centre Zagreb specializing in medicine, adrenal disease, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	360
2	Health Sciences	4	4	135
3	Endocrinology	4	4	162
4	Public Health	1	1	162
5	Epidemiology	1	1	162

Darko Kaštelan

Publications

Citations

H-Index

Page 1

	Year	Citations
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study Irina Bancos, Angela E. Taylor, Vasileios Chortis, The Lancet Diabetes & Endocrinology	2020	233
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in<i>AIP</i>Mutation Carriers Laura C. Hernández‐Ramírez, Plamena Gabrovska, Judit Dénes, The Journal of Clinical Endocrinology & Metabolism	2015	167
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study Timo Deutschbein, Giuseppe Reimondo, Guido Di Dalmazi, The Lancet Diabetes & Endocrinology Adrenal GlandAdrenal IncidentalomasClinical EpidemiologyAutonomous Cortisol SecretionSex-dependent Disparity	2022	162
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma Letizia Canu, Janna A W Van Hemert, Michiel N. Kerstens, The Journal of Clinical Endocrinology & Metabolism	2018	125
Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation Cristina L. Ronchi, Guido Di Dalmazi, Simon Faillot, The Journal of Clinical Endocrinology & Metabolism	2016	87
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma Vasileios Chortis, Irina Bancos, Thomas Nijman, The Journal of Clinical Endocrinology & Metabolism	2019	87
Hypercoagulability in Cushing’s syndrome: the role of specific haemostatic and fibrinolytic markers Darko Kaštelan, Tina Dušek, Ivana Kraljević, Endocrine ThrombosisClinical DisordersCushing ’Cardiovascular DiseasePhysiology	2009	85
High mortality within 90 days of diagnosis in patients with Cushing’s syndrome: results from the ERCUSYN registry Elena Valassi, Antoine Tabarin, Thierry Brue, European Journal of Endocrinology	2019	84
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study Massimo Terzolo, Paola Perotti, Rossella Libé, The Lancet Diabetes & Endocrinology	2023	67
Significant Benefits of <i>AIP</i> Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors Pedro Marques, Francisca Caimari, Laura C. Hernández‐Ramírez, The Journal of Clinical Endocrinology & Metabolism	2020	64

Page 1